Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Single Centre, Open-label, Randomised, Single Dose, Six Period, Reference Replicate, Crossover Study to Evaluate the Bioavailability of MED2005

X
Trial Profile

A Single Centre, Open-label, Randomised, Single Dose, Six Period, Reference Replicate, Crossover Study to Evaluate the Bioavailability of MED2005

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 17 Jan 2020

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Nitroglycerin (Primary) ; Nitroglycerin; Nitroglycerin
  • Indications Erectile dysfunction
  • Focus Pharmacokinetics; Registrational
  • Acronyms FM58
  • Sponsors Futura Medical
  • Most Recent Events

    • 09 Jul 2019 New source identified and integrated (ClinicalTrials.gov: US National Institutes of Health).
    • 02 Jul 2019 Status changed from recruiting to completed.
    • 09 Nov 2018 According to a Futura Medical media release, data from this study will be presented at the 9th Annual Fall Scientific Meeting of SMSNA, (Nov 2018).

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top